Liu Shuang, Yin Feng, Zhang Jianning, Wicha Max S, Chang Alfred E, Fan Wenhong, Chen Ling, Fan Ming, Li Qiao
Department of Neurosurgery, Navy General Hospital PLA, Beijing, 100048, China.
J Cell Biochem. 2014 Aug;115(8):1368-80. doi: 10.1002/jcb.24786.
To investigate the expressional alternation of microRNAs (miRNA) during the malignant transformation and development of human glioma, we measured miRNA expression profile as well as mRNA expression profile in normal human neural stem cells (hNSCs) and human glioma stem cells (hGSCs). We found 116 miRNA up-regulated and 62 miRNA down-regulated in GSCs. On the other hand, we identified 1,372 mRNA down-regulated, and 1,501 mRNA up-regulated in GSCs compared to those in NSCs. We then analyzed the pathways and the predicted target genes of the miRNAs which differ significantly in expression between GSCs and NSCs using the statistical enrichment methods. These target mRNAs are involved in many cancer-related signaling pathways, such as cell cycle, axon guidance, glioma development, adhesion junction, MAPK and Wnt signaling. Furthermore, we obtained the differently expressed miRNA-target relationships according to the θ value which is used to calculate the regulation extent of miRNA-target and using the databases of miRanda, Targetscans and Pictar. Among the top 10 miRNA-target relationships, hsa-miR-198 and its potential targeted gene DCX and NNAT were selected for validation, and NNAT was found to be the direct target of miR-198. Finally, the functional roles of miR-155-5p and miR-124-3p whose expressions altered significantly between GSCs and NSCs were addressed. Our results provide new clues for the potential mechanisms involved in the origin and development of glioma. Clinically, the altered miRNAs may serve as potential targets and diagnostic tools for novel therapeutic strategies of glioblastoma.
为了研究微小RNA(miRNA)在人胶质瘤恶性转化和发展过程中的表达变化,我们检测了正常人神经干细胞(hNSCs)和人胶质瘤干细胞(hGSCs)中的miRNA表达谱以及mRNA表达谱。我们发现GSCs中有116种miRNA上调,62种miRNA下调。另一方面,与NSCs相比,我们在GSCs中鉴定出1372种mRNA下调,1501种mRNA上调。然后,我们使用统计富集方法分析了GSCs和NSCs之间表达差异显著的miRNA的通路和预测靶基因。这些靶mRNA参与许多癌症相关信号通路,如细胞周期、轴突导向、胶质瘤发展、黏附连接、MAPK和Wnt信号通路。此外,我们根据用于计算miRNA-靶标调控程度的θ值,并使用miRanda、Targetscans和Pictar数据库,获得了差异表达的miRNA-靶标关系。在排名前十的miRNA-靶标关系中,选择了hsa-miR-198及其潜在靶基因DCX和NNAT进行验证,发现NNAT是miR-198的直接靶标。最后,探讨了在GSCs和NSCs之间表达显著改变的miR-155-5p和miR-124-3p的功能作用。我们的结果为胶质瘤起源和发展的潜在机制提供了新线索。临床上,改变的miRNAs可能作为胶质母细胞瘤新治疗策略的潜在靶点和诊断工具。